Arcellx, Inc. Files 8-K: Corporate and Financial Update

Ticker: ACLX · Form: 8-K · Filed: Dec 9, 2024 · CIK: 1786205

Arcellx, INC. 8-K Filing Summary
FieldDetail
CompanyArcellx, INC. (ACLX)
Form Type8-K
Filed DateDec 9, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: corporate-filing, financial-reporting

TL;DR

Arcellx filed an 8-K on Dec 8, 2024, covering corporate and financial info. Standard stuff.

AI Summary

Arcellx, Inc. filed an 8-K on December 9, 2024, reporting other events and financial statements. The filing details the company's corporate structure and operational information as of December 8, 2024. Arcellx, Inc. is incorporated in Delaware and operates in the biological products sector.

Why It Matters

This 8-K filing provides essential corporate and financial updates for Arcellx, Inc., which is crucial for investors and stakeholders to understand the company's current status and reporting obligations.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this Form 8-K filing for Arcellx, Inc.?

The Form 8-K is a current report filed by Arcellx, Inc. to disclose material events and financial information as of December 8, 2024.

When was Arcellx, Inc. incorporated, and in which jurisdiction?

Arcellx, Inc. was incorporated in Delaware, as indicated by the filing.

What is the SEC file number for Arcellx, Inc.?

The SEC file number for Arcellx, Inc. is 001-41259.

What is the business address of Arcellx, Inc.?

The business address of Arcellx, Inc. is 800 Bridge Parkway, Redwood City, CA 94065.

What is the SIC code for Arcellx, Inc.?

The Standard Industrial Classification (SIC) code for Arcellx, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-12-09 06:11:00

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated December 8, 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ARCELLX, INC. Date: December 9, 2024 By: /s/ Rami Elghandour Rami Elghandour Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing